Malignant mesenchymal neoplasms of the dermis and subcutis mimicking benign lesions: a case-based review Thomas MentzelThomas Brenn Original Article 12 July 2017 Pages: 565 - 574
Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression Kathleen LambeinMieke Van BockstalLouis Libbrecht Original Article 31 May 2017 Pages: 575 - 587
Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization António PolóniaGuilherme OliveiraFernando Schmitt Original Article 13 July 2017 Pages: 589 - 598
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype Abbas AgaimyFlorian FuchsFlorian Haller Original Article 30 May 2017 Pages: 599 - 609
Small bowel adenocarcinoma complicating Crohn’s disease: a single-centre experience emphasizing the importance of screening for dysplasia Chloé GrolleauNicolas M. PoteDominique L. Cazals-Hatem Original Article 18 April 2017 Pages: 611 - 617
Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series Claudio De VitoDebashis SarkerAlberto Quaglia Original Article 13 July 2017 Pages: 619 - 629
Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques Mustafa MohamedDavid GonzalezKhin Thway Original Article 26 July 2017 Pages: 631 - 640
Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting Ekkehard HewerNadine PrebilErik Vassella Original Article 19 August 2017 Pages: 641 - 649
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome Francesca GaluppiniLoris BertazzaGianmaria Pennelli Original Article 31 August 2017 Pages: 651 - 658
Clinicopathological analysis in PTCL-NOS with CADM1 expression Takeharu KatoHiroaki MiyoshiKoichi Ohshima Original Article 22 September 2017 Pages: 659 - 666
Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center Diana BellAdel K. El-NaggarPaul W. Gidley Brief Report 26 May 2017 Pages: 667 - 672
A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component Hussein NassereddineNicolas PotéAnne Couvelard Brief Report 26 June 2017 Pages: 673 - 678
Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency Mukul VijNaresh P. ShanmugamMohamed Rela Brief Report 21 July 2017 Pages: 679 - 683
About MET expression and other biomarkers in non-small cell lung cancer Laetitia LambrosIsabelle Quintin-RouéArnaud Uguen Letter to the Editor 31 August 2017 Pages: 685 - 686
Response to the letter to the editor of Lambros et al. William SterlacciAlexandar TzankovSpasenija Savic Letter to the Editor 07 September 2017 Pages: 687 - 688